6 months after crash. almost 4 months after pona reinstated. buyout talks should've been taking place by now. at ariads current stage, its unfortunate for dedicated supporters (longs), and patients that need these drugs to be developed asap, without the financial burden.
at the moment, shorts and day traders don't seem concerned about a buyout taking place any time soon. are bergerkings thought process really to blame for no discussions (shame, if thats true)? or is there another explanation as to why talks/bids have yet to begin?